18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.

Kahraman, Deniz; Theurich, Sebastian; Rothe, Achim; Kuhnert, Georg; Sasse, Stephanie; Scheid, Christoph; Dietlein, Markus; Drzezga, Alexander; von Bergwelt-Baildon, Michael; Kobe, Carsten

Kahraman, Deniz; Theurich, Sebastian; Rothe, Achim; Kuhnert, Georg; Sasse, Stephanie; Scheid, Christoph; Dietlein, Markus; Drzezga, Alexander; von Bergwelt-Baildon, Michael; Kobe, Carsten.

Affiliation

Kahraman D; Department of Nuclear Medicine.

Leuk Lymphoma ; 55(4): 811-6, 2014 Apr.

Article in En | MEDLINE | ID: mdl-23805904

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Fluorodeoxyglucose F18; Hodgkin Disease/diagnosis; Hodgkin Disease/drug therapy; Positron-Emission Tomography; Tomography, X-Ray Computed; Adolescent; Adult; Brentuximab Vedotin; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease/mortality; Humans; Immunoconjugates/administration & dosage; Male; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Tomography, X-Ray Computed / Fluorodeoxyglucose F18 / Positron-Emission Tomography Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google